These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 189161)

  • 21. Effect of polymyxin B on the synthesis of prodigiosin and its precursors in Serratia marcescens.
    Tsang JC; Feng JS
    J Antibiot (Tokyo); 1983 Nov; 36(11):1564-6. PubMed ID: 6317625
    [No Abstract]   [Full Text] [Related]  

  • 22. Failure of polymyxin B nonapeptide to augment bactericidal activities of novobiocin, rifampin, and of defibrinated human blood against Serratia marcescens.
    Traub WH; Kohl KH; Spohr M; Bauer D
    Chemotherapy; 1988; 34(3):195-201. PubMed ID: 2843325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular genetics of polymyxin resistance in Salmonella typhimurium.
    Roland KL; Spitznagel JK
    Prog Clin Biol Res; 1995; 392():3-14. PubMed ID: 8524935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Resistance to beta-lactam antibiotics and aminoglycosides in gram negative bacteria. 1. Molecular and genetic characterization of R-factors (author's transl)].
    Schmid B; Kayser FH
    Zentralbl Bakteriol Orig A; 1976 Apr; 234(3):371-83. PubMed ID: 779353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative polyacrylamide electrophoresis of periplasmic proteins released from gram-negative bacteria by polymyxin B.
    Cerny G; Teuber M
    Arch Mikrobiol; 1972; 82(4):361-70. PubMed ID: 4337256
    [No Abstract]   [Full Text] [Related]  

  • 26. Polymyxin B and rifampin: new regimen for multiresistant Serratia marcescens infections.
    Ostenson RC; Fields BT; Nolan CM
    Antimicrob Agents Chemother; 1977 Dec; 12(6):655-9. PubMed ID: 201214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitory effect of polymyxin B on prodigiosin biosynthesis in Serratia marcescens.
    Tsang JC; Sheung X
    J Antibiot (Tokyo); 1980 Apr; 33(4):455-7. PubMed ID: 6251020
    [No Abstract]   [Full Text] [Related]  

  • 28. Some distinctive characteristics of the alkaline phosphatase of Serratia marcescens.
    Bhatti AR
    Can J Biochem; 1975 Jul; 53(7):819-22. PubMed ID: 238723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chromosomal origin of acetyltransferase AAC(6') specifying amikacin resistance in Serratia marcescens.
    Gómez-Lus R; Rivera MJ; Bobey D; Martín C; Navarro M
    Microbiologia; 1987 Oct; 3(3):185-94. PubMed ID: 3077328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of polymyxin B on the fatty acid composition of outer membranes from Serratia marcescens.
    Brown DA; Tsang JC
    J Antibiot (Tokyo); 1977 Feb; 30(2):194-6. PubMed ID: 191428
    [No Abstract]   [Full Text] [Related]  

  • 31. [Dynamics of accumulation of extracellular proteins of Serratia marcescens and their nuclease activity during cell growth].
    Iasnova LN; Puchkova LI
    Mikrobiologiia; 1976; 45(6):979-83. PubMed ID: 796632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Release of the lipopolysaccharide deacylase PagL from latency compensates for a lack of lipopolysaccharide aminoarabinose modification-dependent resistance to the antimicrobial peptide polymyxin B in Salmonella enterica.
    Kawasaki K; China K; Nishijima M
    J Bacteriol; 2007 Jul; 189(13):4911-9. PubMed ID: 17483225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nosocomial outbreak of ceftazidime-resistant Serratia marcescens strains that produce a chromosomal AmpC variant with N235K substitution.
    Yatsuyanagi J; Saito S; Konno T; Harata S; Suzuki N; Kato J; Amano K
    Jpn J Infect Dis; 2006 Jun; 59(3):153-9. PubMed ID: 16785694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Osmotic shock: a mechanosensitive channel blocker can prevent release of cytoplasmic but not periplasmic proteins.
    Ewis HE; Lu CD
    FEMS Microbiol Lett; 2005 Dec; 253(2):295-301. PubMed ID: 16288836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of outer membrane in Serratia marcescens intrinsic resistance to antibiotics.
    Sánchez L; Ruiz N; Leranoz S; Viñas M; Puig M
    Microbiologia; 1997 Sep; 13(3):315-20. PubMed ID: 9353750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of nalidixic acid and mitomycin C on growth and biosynthesis of extracellular proteins by Serratia marcescens].
    Iusupova DV; Sokolova RB; Petukhova EV
    Antibiot Khimioter; 1993; 38(8-9):16-21. PubMed ID: 8037570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pitfalls of polymyxin antimicrobial susceptibility testing of Pseudomonas aeruginosa isolated from cystic fibrosis patients.
    Hogardt M; Schmoldt S; Götzfried M; Adler K; Heesemann J
    J Antimicrob Chemother; 2004 Dec; 54(6):1057-61. PubMed ID: 15509615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence on the presence of two distinct alkaline phosphatases in Serratia marcescens.
    Bhatti AR; Alvi A; Chaudhry GR
    FEMS Microbiol Lett; 2000 Jan; 182(1):131-5. PubMed ID: 10612744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The synergistic action of the sulfonamides and the polymyxins against Serratia marcescens.
    Greenfield S; Feingold DS
    J Infect Dis; 1970 May; 121(5):555-8. PubMed ID: 4316000
    [No Abstract]   [Full Text] [Related]  

  • 40. Leakage of periplasmic proteins from Escherichia coli mediated by polymyxin B nonapeptide.
    Dixon RA; Chopra I
    Antimicrob Agents Chemother; 1986 May; 29(5):781-8. PubMed ID: 3015004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.